NCT04184687

Brief Summary

The aim of the study is the evaluation of both clinical and radiological results in patients undergone to cruciate ligament reconstruction with concomitant cartilaginous lesion treated with or without nanofractures.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
88

participants targeted

Target at P50-P75 for not_applicable

Timeline
14mo left

Started Jul 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress85%
Jul 2019Jul 2027

Study Start

First participant enrolled

July 25, 2019

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

November 28, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

December 3, 2019

Completed
7.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 25, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 25, 2027

Last Updated

May 18, 2025

Status Verified

May 1, 2025

Enrollment Period

8 years

First QC Date

November 28, 2019

Last Update Submit

May 16, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • IKDC-subjective score (International Knee Documentation Committee)

    It is a specific subjective rating scale for te knee. Iti s one of the most reliable tools for assessing knee diseases. The survey examines three categories: symptoms, sport activity, knee function.

    24 month

  • WORMS (Whole-Organ Magnetic Resonance Imaging Score)

    Magnetic resonance imaging will be evaluated through WORMS. The score evaluated five aspects of the three knee compartments (cartilage, bone marrow abnormalities, bone cysts, bone attrition and osteophytes) as well as the soft tissue (menisci, ligaments and synovium)

    24 month

Secondary Outcomes (4)

  • IKDC-subjective score (International Knee Documentation Committee)

    6, 12, 36 and 60 months

  • Tegner Activity Level Scale

    6, 12, 24, 36 and 60 months

  • KOOS (Knee injury and Osteoarthritis Outcome Score )

    6, 12, 24, 36 and 60 months

  • EQ-5D (EuroQoL) Current Health Assessment

    6, 12, 24, 36 and 60 months

Study Arms (2)

Nanofractures treatment of the cartilaginous lesions

EXPERIMENTAL

Patients undergoing to anterior cruciate ligament reconstruction with concomitant treatment of the cartilaginous lesions with nanofractures technique.

Procedure: Nanofractures

no treatment of the cartilaginous lesions

ACTIVE COMPARATOR

Patients undergoing to anterior cruciate ligament reconstruction. Cartilaginous lesions won't be treated

Procedure: no treatment cartilaginous lesions

Interventions

NanofracturesPROCEDURE

anterior cruciate ligament reconstruction will be performed in combination with the nanofractures for the treatment of cartilaginous lesions

Nanofractures treatment of the cartilaginous lesions

patient undergoing to the anterior cruciate ligament reconstruction without treatment of the cartilaginous lesions

no treatment of the cartilaginous lesions

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Male or female patients, 18 \< age \< 55;
  • Patients with complete ACL injury candidates for surgical reconstruction of the same;
  • Cartilaginous lesion of the femur-tibial compartment of grade III-IV ICRS ≤3 cm2 confirmed intra-operatively;
  • Patients without evidence of osteoarthritis
  • Patients' ability and consent to participate in clinical and radiological follow-up;
  • Signature of informed consent.

You may not qualify if:

  • Patients incapable of understanding and of wanting;
  • State of immunodepression;
  • Patients with malignant neoplasms;
  • Patients suffering from rheumatic diseases;
  • Patients suffering from non-compensated diabetes;
  • Patients suffering from uncompensated thyroid metabolic disorders;
  • Patients abusing alcoholic beverages, drugs or drugs;
  • Patients with axial deviations\> 5 °;
  • Body Mass Index\> 35;
  • Patients treated with surgery at the same knee in the previous 12 months.
  • Cartilaginous lesions grade I-II according to the ICRS score.
  • Cartilage lesions with a diameter greater than 3 cm².
  • Non-suturable meniscal lesions requiring meniscectomy\> 50% and patients with previous meniscectomies\> 50% in the same compartment.
  • Need for further associated surgical procedures in addition to the reconstruction of ACL and possibly the nanofractures.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istituto Ortopedico Rizzoli

Bologna, Italy

RECRUITING

Related Publications (2)

  • Filardo G, de Caro F, Andriolo L, Kon E, Zaffagnini S, Marcacci M. Do cartilage lesions affect the clinical outcome of anterior cruciate ligament reconstruction? A systematic review. Knee Surg Sports Traumatol Arthrosc. 2017 Oct;25(10):3061-3075. doi: 10.1007/s00167-016-4097-y. Epub 2016 Apr 4.

    PMID: 27043346BACKGROUND
  • Brophy RH, Zeltser D, Wright RW, Flanigan D. Anterior cruciate ligament reconstruction and concomitant articular cartilage injury: incidence and treatment. Arthroscopy. 2010 Jan;26(1):112-20. doi: 10.1016/j.arthro.2009.09.002.

    PMID: 20117635BACKGROUND

Central Study Contacts

Alessandro Di Martino

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 28, 2019

First Posted

December 3, 2019

Study Start

July 25, 2019

Primary Completion (Estimated)

July 25, 2027

Study Completion (Estimated)

July 25, 2027

Last Updated

May 18, 2025

Record last verified: 2025-05

Locations